BCM
CVS icon

Bluefin Capital Management’s CVS Health CVS Stock Holding History

Bluefin Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,000
Closed -$635K – 140
2025
Q4 		$635K Buy
+8,000
New +$631K 0.16% 81
2023
Q1 		– Sell
-9,760
Closed -$910K – 296
2022
Q4 		$910K Sell
9,760
-4,520
-32% -$436K 0.14% 101
2022
Q3 		$1.36M Buy
14,280
+2,800
+24% +$277K 0.12% 110
2022
Q2 		$1.07M Buy
11,480
+2,745
+31% +$268K 0.12% 124
2022
Q1 		$884K Sell
8,735
-43,565
-83% -$4.58M 0.08% 144
2021
Q4 		$5.39M Buy
52,300
+2,663
+5% +$246K 0.38% 49
2021
Q3 		$4.21M Buy
+49,637
New +$4.16M 0.42% 44
2021
Q2 		– Sell
-24,912
Closed -$1.87M – 724
2021
Q1 		$1.87M Buy
24,912
+7,594
+44% +$553K 0.09% 121
2020
Q4 		$1.18M Buy
+17,318
New +$1.13M 0.07% 164
2020
Q3 		– Sell
-8,880
Closed -$553K – 153
2020
Q2 		$577K Sell
8,880
-8,270
-48% -$521K 0.05% 144
2020
Q1 		$1.02M Sell
17,150
-32,930
-66% -$2.2M 0.13% 119
2019
Q4 		$3.72M Buy
+50,080
New +$3.52M 0.25% 101
2019
Q2 		– Sell
-89,074
Closed -$4.8M – 361
2019
Q1 		$4.8M Sell
89,074
-136,146
-60% -$8.4M 0.69% 29
2018
Q4 		$14.8M Buy
+225,220
New +$16.8M 1.5% 13
2017
Q3 		– Sell
-3,703
Closed -$298K – 502
2017
Q2 		$298K Buy
+3,703
New +$292K 0.03% 288
2016
Q2 		– Sell
-2,203
Closed -$220K – 523
2016
Q1 		$229K Sell
2,203
-4,689
-68% -$456K 0.02% 284
2015
Q4 		$674K Buy
6,892
+217
+3% +$21.3K 0.05% 275
2015
Q3 		$644K Buy
+6,675
New +$702K 0.04% 231
2013
Q3 		– Sell
-7,510
Closed -$400K – 440
2013
Q2 		$400K Buy
+7,510
New +$435K 0.04% 332

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bluefin Capital Management's CVS Position: Q1 2026 in Review

Bluefin Capital Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 8,000 shares — an estimated $635K sold.

Bluefin Capital Management first reported a position in CVS in Q2 2013 and held it in 19 quarters. The position peaked at $14.8M in Q4 2018. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Bluefin Capital Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Bluefin Capital Management sold 8,000 CVS Health shares in Q1 2026, an estimated $635K.
  • Bluefin Capital Management first reported a position in CVS Health in Q2 2013 and held it in 19 quarters.
  • Bluefin Capital Management's CVS Health position peaked at $14.8M in Q4 2018.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.